MassBiologics, a non-profit and FDA-licensed manufacturer based in Boston, specializes in the development and production of biologic products, including vaccines, plasma derivatives, and monoclonal antibodies. With over a century of experience, the organization is dedicated to enhancing public health through applied research and innovative manufacturing processes. Their current offerings include the Tetanus and Diphtheria Toxoids (Td) vaccine, which is distributed nationwide. MassBiologics operates under the mission of "Medicine for Better Lives," focusing on the discovery, development, and manufacturing of biological medicines that cater to diverse patient populations, including those in developing nations with unique health challenges.

The company provides a range of development services, particularly in non-GMP monoclonal antibody and protein production. Their capabilities include mammalian cell culture in various bioreactor sizes, from shake flasks to 60L stirred tank bioreactors, allowing for the production of materials in scales from milligrams to tens of grams. MassBiologics employs standardized programs for antibody production, which encompass cloning, plasmid production, electroporation, and purification processes. Their expertise in analytical method development, cell line and culture development, formulation, and downstream process development further supports their commitment to delivering high-quality biologic products tailored to client specifications.

United States

MassBiologicsis a non-profit FDA-licensed manufacturer of vaccines. For over 100 years, MassBiologics has worked to improve public health through applied research, development and production of biologic products, including vaccines, plasma derivatives and more recently, monoclonal antibodies. MassBiologics currently manufactures Tetanus and Diptheria Toxoids, Adsorbed (Td) vaccine and distributes them nationwide.

MassBiologics

Company Details